U.S. Food and Drug Administration

• 

  Stocks slide on "fiscal cliff" warning

  By Steve Rothwell  |  November 27, 2012

  Stocks slumped on Wall Street Tuesday after Senate Majority Leader Harry Reid said he was frustrated by the lack of progress in talks over the U.S. budget impasse in Washington.

• GlaxoSmithKline settles healthcare fraud case for $3 billion (Reuters)

  By Staff Writer  |  July 3, 2012

  Still awaiting court approval, it would settle allegations that the company broke U.S. laws in marketing and development of pharmaceuticals.

• Arkansas Judge Fines J&J $1.1B in Risperdal Case

  By Chuck Bartels, Associated Press  |  April 12, 2012

  Officials have accused the manufacturer of misleading the state Medicaid program.

• 

  Weird Science

  By Allison Bell  |  April 1, 2012

  When do insurers decide an experimental treatment is worth covering?

• 

  FDA OKs Once-a-Week Successor to Injectable Diabetes Drug

  By MATTHEW PERRONE, AP Health Writer  |  January 30, 2012

  The monthly cost for users of an older version, Byetta, who switch to the new version could rise to $323, from $291.

• 

  Avalere: Benchmark Plan Candidates Cover Many Drugs

  By Allison Bell  |  January 26, 2012

  Analysts did find some variation in the formularies that could shape the essential health benefits standards.

• 

  HealthPix

  By Allison Bell  |  October 10, 2011

  "Health is the true wealth" and other images from the worlds of medical, disability and long-term care insurance.